Skip to main content
. 2011 Jun 22;56(11):3220–3225. doi: 10.1007/s10620-011-1758-z

Fig. 2.

Fig. 2

Gastric juice EGF in controls (Ctrl), chronic atrophic gastritis (CAG), chronic atrophic gastritis/intestinal metaplasia (CAG/IM), and chronic atrophic gastritis/intestinal metaplasia/adenocarcinoma (CAG/IM/AdCa)